IUHSA
TXG icon

Itau Unibanco Holding S.A.’s 10x Genomics TXG Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-180
Closed -$3.5K – 430
2024
Q2 		$3.5K Buy
+180
New +$4.71K ﹤0.01% 331
2024
Q1 		– Sell
-332
Closed -$18.6K – 343
2023
Q4 		$18.6K Sell
332
-78
-19% -$3.39K ﹤0.01% 282
2023
Q3 		$16.9K Sell
410
-1
-0.2% -$52 ﹤0.01% 383
2023
Q2 		$22.9K Buy
411
+15
+4% +$812 ﹤0.01% 394
2023
Q1 		$22.1K Hold
396
– – ﹤0.01% 392
2022
Q4 		$14.4K Sell
396
-77
-16% -$2.52K ﹤0.01% 432
2022
Q3 		$13K Hold
473
– – ﹤0.01% 481
2022
Q2 		$21K Buy
473
+218
+85% +$11.3K ﹤0.01% 389
2022
Q1 		$19K Hold
255
– – ﹤0.01% 385
2021
Q4 		$38K Sell
255
-77
-23% -$11.8K ﹤0.01% 329
2021
Q3 		$48K Hold
332
– – ﹤0.01% 273
2021
Q2 		$65K Buy
+332
New +$60.1K ﹤0.01% 154

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Itau Unibanco Holding S.A.'s TXG Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 180 shares — an estimated $3.5K sold.

Itau Unibanco Holding S.A. first reported a position in TXG in Q2 2021 and held it in 12 quarters. The position peaked at $65K in Q2 2021. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 180 10x Genomics shares in Q3 2024, an estimated $3.5K.
  • Itau Unibanco Holding S.A. first reported a position in 10x Genomics in Q2 2021 and held it in 12 quarters.
  • Itau Unibanco Holding S.A.'s 10x Genomics position peaked at $65K in Q2 2021.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.